A detailed history of Silvercrest Asset Management Group LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 5,835 shares of XBI stock, worth $532,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,835
Previous 5,835 -0.0%
Holding current value
$532,385
Previous $540,000 6.67%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$82.22 - $94.12 $479,753 - $549,190
-5,835 Reduced 50.0%
5,835 $540,000
Q2 2024

Aug 14, 2024

BUY
$82.22 - $94.12 $479,753 - $549,190
5,835 Added 100.0%
11,670 $1.08 Million
Q1 2024

May 15, 2024

BUY
$87.05 - $102.89 $870 - $1,028
10 Added 0.17%
5,835 $553,000
Q1 2023

May 15, 2023

BUY
$73.13 - $91.97 $425,982 - $535,725
5,825 New
5,825 $443,000

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.